Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Aravis Strengthens Life Science Team with Three Important Appointments

Published: Friday, January 10, 2014
Last Updated: Thursday, January 09, 2014
Bookmark and Share
Dr Dani Bach (formerly of Index Ventures) joins as Managing Partner, Dr Jacques Mizrahi joins in a consulting role as Venture Partner and Kadri Vunder (formerly LSVenture) as a Partner.

Aravis has announced the appointment of three new members of the life science investment team.

Dr Dani Bach joins Aravis in February 2014 as Managing Partner within the life science team. Dani was previously part of the life sciences team at Geneva based venture fund, Index Ventures, having joined the firm in 2007.

Dani’s investment interests have focused on protein therapeutics, neurodegeneration, and medical devices. Prior to joining Index, Dani held a research position at the Ecole Polytechnique Federal de Lausanne (EPFL), where he worked on the complex interactions between human immunodeficiency virus (HIV) and the human immune system. Dani holds a PhD in Molecular Biology from the University of Barcelona.

Dr Jacques Mizrahi began consulting Aravis as a Venture Partner in mid-2013. Dr Mizrahi has over 20 years of experience in drug discovery, drug development and translational medicine for many large pharma companies including Roche where his last position was as an Executive Leader, Cardiovascular & Metabolic Diseases. He has a PhD in pharmacology from Sherbrooke University, Quebec Canada.

Dr Kadri Vunder joined Aravis’ life science team as a Partner mid-2013. Dr. Vunder has over 10 years investment and executive management experience in the biotech, chemical and financial industries. Prior to joining Aravis, Kadri built up and managed a biotechnology oriented seed investment firm LSVenture.

Kadri holds a PhD in Economics from the University of St. Gallen and scientific degrees from the Tallinn Technical University in Biotechnology and Analytical Chemistry.

Dr Simon Nebel, Founder and Managing Partner at Aravis said :“2014 will be an important year for us and we are excited to be starting it with the appointment of these high caliber team members. I am confident that their deep knowledge and proven expertise in the life science sector will be advantageous for Aravis’ future enterprises.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!